Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebral Oxygenation with Poractant vs Beractant in Preterm Newborns
NCT01941524Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Mar 2013
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in respiratory distress syndrome (RDS) comparing Poractant group with Beractant group (2 arms). Primary endpoints: Cerebral tissue oxygenation at 4 hours and Brain bioelectrical activity at 4 hours. Started Mar 2013; status: completed.
02
Drugs
Poractant alfaberactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT01941524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941524.